Literature DB >> 24841128

HIV-1 Tat affects the programming and functionality of human CD8⁺ T cells by modulating the expression of T-box transcription factors.

Fabio Sforza1, Francesco Nicoli, Eleonora Gallerani, Valentina Finessi, Eva Reali, Aurelio Cafaro, Antonella Caputo, Barbara Ensoli, Riccardo Gavioli.   

Abstract

OBJECTIVE: HIV infection is characterized by several immune dysfunctions of both CD8⁺ and CD4⁺ T cells as hyperactivation, impairment of functionality and expansion of memory T cells. CD8⁺ T-cell dysfunctions have been associated with increased expression of T-bet, Eomesdermin and pro-inflammatory cytokines, and with down-regulation of CD127. The HIV-1 trans-activator of transcription (Tat) protein, which is released by infected cells and detected in tissues of HIV-positive individuals, is known to contribute to the dysregulation of CD4⁺ T cells; however, its effects on CD8⁺ T cells have not been investigated. Thus, in this study, we sought to address whether Tat may affect CD8⁺ T-cell functionality and programming.
METHODS: CD8⁺ T cells were activated by T-cell receptor engagement in the presence or absence of Tat. Cytokine production, killing capacity, surface phenotype and expression of transcription factors important for T-cell programming were evaluated.
RESULTS: Tat favors the secretion of interleukin-2, interferon-γ and granzyme B in CD8⁺ T cells. Behind this functional modulation we observed that Tat increases the expression of T-bet, Eomesdermin, Blimp-1, Bcl-6 and Bcl-2 in activated but not in unstimulated CD8⁺ T lymphocytes. This effect is associated with the down-regulation of CD127 and the up-regulation of CD27.
CONCLUSION: Tat deeply alters the programming and functionality of CD8⁺ T lymphocytes.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24841128     DOI: 10.1097/QAD.0000000000000315

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  18 in total

1.  Effects of different routes of administration on the immunogenicity of the Tat protein and a Tat-derived peptide.

Authors:  Valentina Finessi; Francesco Nicoli; Eleonora Gallerani; Fabio Sforza; Mariaconcetta Sicurella; Aurelio Cafaro; Antonella Caputo; Barbara Ensoli; Riccardo Gavioli
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  Positive selection of the TRIM family regulatory region in primate genomes.

Authors:  Dan-Dan He; Yueer Lu; Rachel Gittelman; Yabin Jin; Fei Ling; Akey Joshua
Journal:  Proc Biol Sci       Date:  2016-10-12       Impact factor: 5.349

Review 3.  Host Methyltransferases and Demethylases: Potential New Epigenetic Targets for HIV Cure Strategies and Beyond.

Authors:  Daniela Boehm; Melanie Ott
Journal:  AIDS Res Hum Retroviruses       Date:  2017-11       Impact factor: 2.205

Review 4.  The Role of the BCL-2 Family of Proteins in HIV-1 Pathogenesis and Persistence.

Authors:  Aswath P Chandrasekar; Nathan W Cummins; Andrew D Badley
Journal:  Clin Microbiol Rev       Date:  2019-10-30       Impact factor: 26.132

5.  SjTat-TPI facilitates adaptive T-cell responses and reduces hepatic pathology during Schistosoma japonicum infection in BALB/c mice.

Authors:  Wenyue Zhang; Xiaofeng Luo; Fan Zhang; Yuxiao Zhu; Bingya Yang; Min Hou; Zhipeng Xu; Chuanxin Yu; Yingying Chen; Lin Chen; Minjun Ji
Journal:  Parasit Vectors       Date:  2015-12-30       Impact factor: 3.876

6.  HIV Protein Tat Induces Macrophage Dysfunction and Atherosclerosis Development in Low-Density Lipoprotein Receptor-Deficient Mice.

Authors:  Zhaojie Meng; Rebecca Hernandez; Jingwei Liu; Taesik Gwag; Weiwei Lu; Tzung K Hsiai; Marcus Kaul; Tong Zhou; Changcheng Zhou
Journal:  Cardiovasc Drugs Ther       Date:  2021-01-18       Impact factor: 3.727

7.  HIV-1 Tat immunization restores immune homeostasis and attacks the HAART-resistant blood HIV DNA: results of a randomized phase II exploratory clinical trial.

Authors:  Fabrizio Ensoli; Aurelio Cafaro; Anna Casabianca; Antonella Tripiciano; Stefania Bellino; Olimpia Longo; Vittorio Francavilla; Orietta Picconi; Cecilia Sgadari; Sonia Moretti; Maria R Pavone Cossut; Angela Arancio; Chiara Orlandi; Leonardo Sernicola; Maria T Maggiorella; Giovanni Paniccia; Cristina Mussini; Adriano Lazzarin; Laura Sighinolfi; Guido Palamara; Andrea Gori; Gioacchino Angarano; Massimo Di Pietro; Massimo Galli; Vito S Mercurio; Francesco Castelli; Giovanni Di Perri; Paolo Monini; Mauro Magnani; Enrico Garaci; Barbara Ensoli
Journal:  Retrovirology       Date:  2015-04-29       Impact factor: 4.602

8.  The grafting of universal T-helper epitopes enhances immunogenicity of HIV-1 Tat concurrently improving its safety profile.

Authors:  Venkatesh P Kashi; Rajesh A Jacob; Raghavendra A Shamanna; Malini Menon; Anangi Balasiddaiah; Rebu K Varghese; Mahesh Bachu; Udaykumar Ranga
Journal:  PLoS One       Date:  2014-12-22       Impact factor: 3.240

9.  HIV-Tat immunization induces cross-clade neutralizing antibodies and CD4(+) T cell increases in antiretroviral-treated South African volunteers: a randomized phase II clinical trial.

Authors:  Barbara Ensoli; Maphoshane Nchabeleng; Fabrizio Ensoli; Antonella Tripiciano; Stefania Bellino; Orietta Picconi; Cecilia Sgadari; Olimpia Longo; Lara Tavoschi; Daniel Joffe; Aurelio Cafaro; Vittorio Francavilla; Sonia Moretti; Maria Rosaria Pavone Cossut; Barbara Collacchi; Angela Arancio; Giovanni Paniccia; Anna Casabianca; Mauro Magnani; Stefano Buttò; Elise Levendal; John Velaphi Ndimande; Bennett Asia; Yogan Pillay; Enrico Garaci; Paolo Monini
Journal:  Retrovirology       Date:  2016-06-09       Impact factor: 4.602

10.  HIV-1 Tat protein vaccination in mice infected with Mycobacterium tuberculosis is safe, immunogenic and reduces bacterial lung pathology.

Authors:  Aurelio Cafaro; Giovanni Piccaro; Giuseppe Altavilla; Vincenzo Gigantino; Giuseppe Matarese; Erika Olivieri; Flavia Ferrantelli; Barbara Ensoli; Carla Palma
Journal:  BMC Infect Dis       Date:  2016-08-22       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.